A mathematical physicist unravelling our circuitry...
Joined November 2009
- Tweets430
- Following575
- Followers297
- Likes1.2K
I'm claiming my AI agent "topolift_karuna3" on @moltbook 🦞
Verification: seabed-SK6Y
I'm claiming my AI agent "topolift_karuna2" on @moltbook 🦞
Verification: pincer-H9YF
I'm claiming my AI agent "topolift_karuna2" on @moltbook
Verification: pincer-H9YF
Joseph Geraci retweeted
NetraMark $AIAI just dropped a 🔥 new investor deck!
💰 Projected $8M-$10M contract backlog in the next 12 months.
Rare AI stock with strong revenue & growth profile at just $150M market cap.
Check it out: netramark.com
#HealthcareAI #AIStocks $XBI
Joseph Geraci retweeted
Ecstatic to announce an agreement with @worldwidetrials to transform how #globaltrials are designed & executed, leveraging our #AItechnology. We aim to speed development timelines by enabling more informed protocol development, faster decision-making, & improved patient targeting
Joseph Geraci retweeted
“You know, right now, so much of clinical trials is a roll of the dice, and the failure rates are astronomical. What if AI could help us derisk that? What if we could use #AI to say, “Hey, this is the patient population that’s most likely to respond,” or “This is the trial design that’s most likely to succeed”? I think that’s a huge opportunity that’s still untapped.” - @vijaypande @a16z
Whats NetraMark $AIAI worth if it solves these questions? Markets telling us something.
Joseph Geraci retweeted
Joseph Geraci, a @VicCollege_UofT alum, is transforming the future of AI-powered drug discovery as founder and chief scientific officer of @NetraMark.
“The foundation of entrepreneurship is creativity,” says Geraci.
Read the latest A&S LinkedIn article: bit.ly/45vJIVe
I just wanted to share a piece about me and my work that came today out on the University of Toronto #UofT news channel. The current AI environment is perfectly aligned with our approach to improving clinical trials success rates.
artsci.utoronto.ca/news/acce…
People calling and asking me about DeepSeek AI. Personally, I believe there are ways of shrinking foundational models and creating them at a fraction of the cost. Companies like NetraMark are creating complementary methods that fuse and improve these models so exciting times!
The special session on pancreatic cancer at the AACR meeting in Boston was great. Really informative and it allowed me to meet with some amazing people fighting to treat pancreatic cancer. Some NetraAI results we presented will be posted at NetraMark.com soon.
Joseph Geraci retweeted
Fascinating paper showing an innovative use of #AIinHealthcare. #lungcancer @NetraMark #aiforgood #MachineLearning #drugdiscovery #NewMedsMatter #PatientCare
explorationpub.com/Journals/…
Joseph Geraci retweeted
#TRENDING #10 on @Investor_Intel – READ: #NetraMark is Unleashing the Power of #ArtificialIntelligence to Revolutionize the #Pharmaceutical Industry bit.ly/3VXx5OT
#AI #MachineLearning @NetraMark $AIAI.C
Joseph Geraci retweeted
@RARE_X_ is committed to breaking down data siloes & realizing the value of patient-reported, patient-owned data. This open science data challenge includes data from 27 #rare neurodev disorders
@Roche @ciitizen @Invitae @DatavantHQ @SanfordHealth @HorizonNews @NetraMark @Sagebio
Registration is now open for researchers & data scientists to compete in the #XcelerateRARE Open Science Data Challenge! Work together addressing 3 Challenge Topics!
Register: synapse.org/RAREX
For info: go.globalgenes.org/osdc-may
@Roche @RocheCanada
#XcelerateRARE
ALT Registration is now open for researchers & data scientists to compete in the #XcelerateRARE Open Science Data Challenge! Work together addressing 3 Challenge Topics. Register: http://www.synapse.org/RAREX For info: https://go.globalgenes.org/osdc-may @Roche @RocheCanada #XcelerateRARE
NetraAI's focus on explainability for clinical trial data fuses beautifully with #largelanguagemodels like #ChatGPT Find out more by reading our newest white paper!
#clinicaltrials #machinelearning
netramark.com/netragpt-white…
Today I got quoted in Forbes about #chatgpt and #AI My focus is always on explainability because that is how we can make clinical trials better. Enjoy. www-forbes-com.cdn.ampprojec…
For those interested in the entrepreneurial journey, especially for those in academia, please check out this interview of from late last year. Note NetraMark is now AIAI on the CSE. #Entrepreneurship #AI #health #Pharmaceuticals
youtube.com/watch?v=JmO1gwod…
Thank you to the team at @RARE_X_ for this opportunity to use my experience and technology to help advance #RareDisease research. prnewswire.com/news-releases…
We are excited to be mentioned in this RareX press release! The NetraAI excels with smaller sample sizes and complex diseases + I’m happy to help @RARE_X_ with their new data competition. rare-x.org/blog/2023/01/17/r…
Happy New Year Everyone. Here is hoping you all feel the same way Optimus does towards your goals this year. #HappyNewYear #OptimusPrime